Status:
COMPLETED
Maintenance Transcranial Electrical Stimulation for Depression
Lead Sponsor:
The University of New South Wales
Conditions:
Major Depressive Disorder
Bipolar Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Transcranial electrical stimulation (TES) techniques offer a novel treatment approach for depression and have shown promising efficacy. However, there is no published data to date on their effectivene...
Eligibility Criteria
Inclusion
- All participants will be ≥ 18 years old.
- Participants must have experienced a significant clinical response, defined as ≥ 50% decrease from baseline scores on the Montgomery Asberg Depression Rating Scale (MADRS).
Exclusion
- Inadequate response to acute trial of TES.
- Suicidality.
- Clinically defined neurological disorder or insult.
- Metal in the cranium, skull defects, or skin lesions on scalp (cuts, abrasions, rash) at proposed electrode sites.
- Pregnancy (women of childbearing age will be asked to undergo a urine pregnancy test prior to starting the study).
- Concurrent long acting benzodiazepines, ritalin or dexamphetamine medication.
- Treatment for depression is changed during months 3-9 of the trial.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2018
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01890356
Start Date
June 1 2013
End Date
February 1 2018
Last Update
March 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Black Dog Institute / University of New South Wales
Randwick, Sydney, New South Wales, Australia, 2031